CUTANEOUS SQUAMOUS CELL CANCER
Clinical trials for CUTANEOUS SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EVOLVE104 takes on tough cancers in early human trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell carcinoma (lung, esophagus, skin, and others). The study aims to find a safe dose and see if the drug can shrink tumors. It is for pati…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New cancer drug sigvotatug vedotin enters human trials
Disease control Recruiting nowThis early-stage trial is testing a new drug called sigvotatug vedotin, alone or with other cancer medicines, in people with advanced solid tumors like lung, head and neck, and breast cancers. The study aims to find a safe dose and check for side effects. About 1,000 participants…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Flu vaccine injected into skin tumors: a new cancer weapon?
Knowledge-focused Recruiting nowThis early-phase trial is testing whether injecting the seasonal flu vaccine directly into skin cancer tumors can boost the immune system's attack on the cancer. About 25 people with cutaneous squamous cell carcinoma will receive one injection into their tumor before standard sur…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC